Congestion
17
3
4
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
5.9%
1 terminated out of 17 trials
85.7%
-0.8% vs benchmark
18%
3 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (17)
Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention
SURE-HF: Urinary Sodium-Guided Diuretic Therapy in Heart Failure
Urinary Chloride and Sodium Changes and Residual Congestion in Acute Heart Failure
SUbCONgestion in Heart Failure Registry
ERTU-SODIUM: Study on the Effects of Ertugliflozin on Sodium Storage, Interstitial Volume, and Plasma Volume in HFrEF
Training Medical Residents in the Use of the Venous Excess UltraSound (VExUS) Score for Bedside Volume Assessment.
Portal Vein Flow Variability to Quantify Right-Sided Hemodynamic Congestion (PORTAL)
Optimization of Fluid Balance Guided by Bioelectrical Impedance Analysis in Patients Undergoing Continuous Renal Replacement Therapy in Critical Care
PVP-Guided Decongestive Therapy in HF 2
Determinants of Portal Vein Pulsatility Index
Sodium Chloride vs. Glucose Solute as a Volume Replacement Therapy During Decongestion in Acute Heart Failure
Biomarkers for the Assessment of Congestion in Patients With Ambulatory and Hospitalised Heart Failure
Ultrasound-guided Treatment in Acute Heart Failure
Alleviation of Common Cold Symptoms
ClearUP Longitudinal Pilot Study
Comparison of Non-invasive to Invasive Assessment of Jugular Venous Pressure
VoIce Changes and Heart Failure